Inventor · disambiguated record
Roger J. Hajjar
Also filed as: HAJJAR ROGER · HAJJAR ROGER J · HAJJAR ROGER JOSEPH
15 granted patents·31 pending applications·260 citations·filing 2001–2025
91Inventor score
Files withICAHN SCHOOL MED MOUNT SINAI9FLAGSHIP PIONEERING INNOVATIONS V INC7ABIOMED INC5GEN HOSPITAL CORP3HAJJAR ROGER J3
Top patents by PatentIndex Score
46 records- 0195US12213771B2Thermistor imbedded therapeutic catheterABIOMED INC·Filed 2022·Granted Feb 4, 2025·11 cites·20 claims
- 0295US12064120B2Systems and methods for left ventricular unloading in biologic therapy or vectored gene therapyABIOMED INC·Filed 2020·Granted Aug 20, 2024·12 cites·6 claims
- 0393US8404658B2RNA interference for the treatment of heart failureHAJJAR ROGER J·Filed 2008·Granted Mar 26, 2013·204 cites·11 claims
- 0491US11285310B2Thermistor imbedded therapeutic catheterABIOMED INC·Filed 2018·Granted Mar 29, 2022·15 cites·9 claims
- 0582US7291604B2Methods of treating restenosisGEN HOSPITAL CORP·Filed 2004·Granted Nov 6, 2007·14 cites·8 claims
- 0678US2025194943A1Thermistor imbedded therapeutic catheterABIOMED INC·Filed 2024·Application pending·0 cites
- 0772US2025009357A1Systems and methods for left ventricular unloading in biologic therapy or vectored gene therapyABIOMED INC·Filed 2024·Application pending·0 cites
- 0870US11213534B2Modulating phosphatase activity in cardiac cellsTHE UNIV OF CINCINNATI·Filed 2016·Granted Jan 4, 2022·1 cites·15 claims
- 0970US9114148B2Modulating phosphatase activity in cardiac cellsHAJJAR ROGER J·Filed 2005·Granted Aug 25, 2015·1 cites·16 claims
- 1070US2020171059A1Modulating phosphatase activity in cardiac cellsTHE UNIV OF CINCINNATI·Filed 2019·Application pending·0 cites
- 1167US12343353B2Modulating phosphatase activity in cardiac cellsTHE UNIV OF CINCINNATI·Filed 2019·Granted Jul 1, 2025·0 cites·12 claims
- 1266US2022372519A1In vitro assembly of anellovirus capsids enclosing rnaFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2022·Application pending·0 cites
- 1365US9845320B2Benzothiazole or benzoxazole compounds as sumo activatorsICAHN SCHOOL MED MOUNT SINAI·Filed 2013·Granted Dec 19, 2017·1 cites·9 claims
- 1464US10888588B2Directed cardiomyocyte differentiation and ventricular specification of stem cellsICAHN SCHOOL MED MOUNT SINAI·Filed 2014·Granted Jan 12, 2021·1 cites·13 claims
- 1564US2024415978A1Anellovectors for delivery of effectors to the central nervous systemFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2024·Application pending·0 cites
- 1663US2025257368A1In vitro assembly of anellovirus capsids enclosing rnaFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2025·Application pending·0 cites
- 1763US2025213725A1Novel anelloviridae family vector compositions and methodsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2023·Application pending·0 cites
- 1862US2019060424A1Sumoylation of Serca2A and Cardiovascular DiseaseICAHN SCHOOL MED MOUNT SINAI·Filed 2018·Application pending·0 cites
- 1961US2024327867A1Anellovirus constructs comprising recombination sites and cross-packaging of anellovector particles and genetic elementsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2024·Application pending·0 cites
- 2060US2024408241A1Novel anellovector compositions and methodsFLAGSHIP PIONEERING INNOVATION V INC·Filed 2022·Application pending·0 cites
- 2160US2025320465A1Compositions comprising modified anellovirus capsid proteins and uses thereofFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2023·Application pending·0 cites
- 2259US10105422B2Sumoylation of SERCA2a and cardiovascular diseaseICAHN SCHOOL MED MOUNT SINAI·Filed 2016·Granted Oct 23, 2018·0 cites·5 claims
- 2358US2009239940A1Treating heart failure and ventricular arrhythmiasDEL MONTE FEDERICA·Filed 2009·Application pending·0 cites
- 2457US10479816B2Decoy peptides inhibiting protein phosphatase 1-medicated dephosphorylation of phospholambanBETHPHAGEN INC·Filed 2018·Granted Nov 19, 2019·0 cites·5 claims
- 2556US10208085B2Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of phospholambanGWANGJU INST SCIENCE & TECH·Filed 2013·Granted Feb 19, 2019·0 cites·5 claims
- 2656US2023227849A1Methods of identifying and characterizing anelloviruses and uses thereofFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
- 2754US2023181722A1Coronavirus antigen compositions and their usesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Application pending·0 cites
- 2852US2023340528A1Methods of treating cardiac disorders and congestive heart failure and administering aav vectorsTRETIAKOVA ANNA·Filed 2021·Application pending·0 cites
- 2951US2023203192A1Compositions and methods for producing human polyclonal antibodiesFLAGSHIP PIONEERING INC·Filed 2021·Application pending·0 cites
- 3051US2005095227A1Treating heart failureGEN HOSPITAL CORP·Filed 2004·Application pending·0 cites
- 3151US2024058475A1Methods and compositions for treating muscular dystrophySARDOCOR CORP·Filed 2022·Application pending·0 cites
- 3251US2015316551A1Sumoylation of SERCA2a and Cardiovascular DiseaseHAJJAR ROGER JOSEPH·Filed 2015·Application pending·0 cites
- 3349US2022088049A1Compositions, methods, and kits for delivery of polyribonucleotidesFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2020·Application pending·0 cites
- 3448US8133878B1Methods for treating restenosisHAJJAR ROGER J·Filed 2010·Granted Mar 13, 2012·0 cites·10 claims
- 3548US2017065685A1Serca2 therapeutic compositions and methods of useICAHN SCHOOL MED MOUNT SINAI·Filed 2016·Application pending·0 cites
- 3648US2014234287A1SUMOYLATION OF SERCA2a AND CARDIOVASCULAR DISEASEHAJJAR ROGER JOSEPH·Filed 2012·Application pending·0 cites
- 3747US2008112930A1Methods of treating restenosisGEN HOSPITAL CORP·Filed 2007·Application pending·0 cites
- 3847US2020270638A1Exosomes as a vector for gene delivery in resistance to neutralizing antibody and methods of their manufactureICAHN SCHOOL MED MOUNT SINAI·Filed 2018·Application pending·0 cites
- 3946US10501453B2Benzothiazole or benzoxazole compounds as SUMO activatorsICAHN SCHOOL MED MOUNT SINAI·Filed 2017·Granted Dec 10, 2019·0 cites·16 claims
- 4046US2011256101A1Serca2 therapeutic compositions and methods of useSINAI SCHOOL MEDICINE·Filed 2011·Application pending·0 cites
- 4145US2018099029A9Serca2 therapeutic compositions and methods of useCELLADON CORP·Filed 2013·Application pending·0 cites
- 4245US2013243730A1Rna interference for the treatment of heart failureNANOCOR THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4344US2020270240A1Benzothiazole and pyridothiazole compounds as sumo activatorsICAHN SCHOOL MED MOUNT SINAI·Filed 2018·Application pending·0 cites
- 4441US2014243387A1Methods for improving cardiac contractilityICAHN SCHOOL MED MOUNT SINAI·Filed 2013·Application pending·0 cites
- 4540US2002040010A1Use of agents to treat heart disordersFiled 2001·Application pending·0 cites
- 4639US2002110910A1Isolation procedure and optimized media solution to enhance long-term survival of cellsGWATHMEY INC·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roger J. Hajjar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →